Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Everest Medicines Enters into Agreement with Gilead Sciences for Trodelvy in Asia Territories 2022-08-16 07:15
ROKIT Healthcare to Enable Innovation in Treatment of Diabetes Foot and Osteoarthritis Combining AI and 3D Bioprinting on Google Cloud 2022-08-12 20:00
Seegene reports H1 2022 financial results 2022-08-12 19:00
Menarini Group's Elacestrant Granted Priority Review by the U.S. FDA for Patients with ER+/HER2- Advanced or Metastatic Breast Cancer 2022-08-11 20:08
Everest Medicines Announces Regulatory Update and Strategic Partnership for Xerava™ in Taiwan 2022-08-11 08:00
Recbio announces Phase III Clinical Trial Progress Of Recombinant HPV 9-Valent Vaccine 2022-08-10 16:06
Starpharma signs new DEP® agreement with MSD 2022-08-10 15:29
MedAlliance SELUTION SLR Receives Second FDA IDE Approval 2022-08-10 10:00
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Moderate-to-severe Plaque Psoriasis Met Primary Endpoint 2022-08-10 08:00
ONESIGHT ESSILORLUXOTTICA FOUNDATION ANNOUNCES PUBLICATION OF NEW ARTICLE 2022-08-10 02:00
Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global Enlightened Growth Leadership Award for its Commitment to Sustainable Growth 2022-08-09 21:17
Merck Becomes One of the First CDMOs to Provide Full Viral Vector Offering with Launch of VirusExpress® 293 Adeno-Associated Virus Production Platform 2022-08-09 20:00
Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol® 2022-08-09 19:00
First Patient Dosed in Phase II Study of KN046 Combined with Axitinib for the First Line Treatment of Advanced Non-Small Cell Lung Cancer 2022-08-09 11:18
Sciwind Biosciences Reports Positive Interim Results from Phase 1c/2a Clinical Trial of XW003 (Ecnoglutide) in Overweight and Obese Adult Volunteers in China 2022-08-09 08:00
FRONTIER BIOTECHNOLOGIES ANNOUNCES POSITIVE PHASE 1 RESULTS OF ITS FIRST CORONAVIRUS MAIN PROTEASE (MPRO) SMALL MOLECULE INHIBITOR, LAYING FOUNDATION FOR THE TREATMENT OF ACUTE AND LONG COVID 2022-08-09 00:00
Prominent Stanford University scientist and cellular reprogramming innovator will oversee all research for Turn Bio 2022-08-08 20:00
Prenetics Launches Circle Snapshot, Simple At-home Blood Tests Using the World's First Push-Button and Painless Blood Collection Device 2022-08-08 16:45
Xinhua Silk Road: E. China's Wuxi city steps up biomedical industry development 2022-08-08 12:24
Qmed Asia launches Qmed GO "Mini Clinics" to Solve Rising Employee Healthcare Costs 2022-08-08 10:15
1 158 159 160 161 162 519